Cha Biotech Decides on 250 Billion KRW Rights Offering to Shareholders
KOSDAQ-listed company Cha Biotech announced on the 20th that it has decided to conduct a rights offering followed by a general public offering of forfeited shares to raise approximately 250 billion KRW for operating funds and other purposes.
Hot Picks Today
![[Breaking] KOSPI Surpasses 6,400 Mark for the First Time Ever During Trading](https://cwcontent.asiae.co.kr/asiaresize/93/2026042109022233670_1776729742.png)
[Breaking] KOSPI Surpasses 6,400 Mark for the F...
- "When the Middle East War Ends, This Stock Will Lead"... Target Price Raised 71%...
- "Is the Starting Salary Really 4 Million Won?"... Surprise as Navy Salary and Sa...
- Why SK Hynix Was Rejected While Samsung Electronics Was Approved: The Reason for...
- Even With a 900 Million Won Deposit and 2.5 Million Won Monthly Living Expenses,...
The issue price is 10,800 KRW per share, and 23,148,150 common shares will be issued.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
